Characterization of RBD-specific cross-neutralizing antibodies responses against SARS-CoV-2 variants from COVID-19 convalescents.
Wang Z, Li D, Chen Y, Sun Y, Jin C, Hu C, Feng Y, Su J, Ren L, Hao Y, Wang S, Zhu M, Liu Y, Qi J, Zhu B, Shao Y.
Wang Z, et al. Among authors: zhu b, zhu m.
Front Immunol. 2023 May 10;14:1160283. doi: 10.3389/fimmu.2023.1160283. eCollection 2023.
Front Immunol. 2023.
PMID: 37234155
Free PMC article.